introduct
respiratori
virus
main
caus
upper
lower
respiratori
tract
diseas
rapid
accur
detect
respiratori
virus
crucial
appropri
patient
treatment
prevent
endem
spread
object
compar
two
multiplex
polymeras
chain
reaction
pcr
assay
detect
respiratori
viral
pathogen
method
total
respiratori
specimen
sputum
sampl
bronchoalveolar
lavag
sampl
nasal
swab
throat
swab
unknown
analyz
use
two
multiplex
assay
onestep
rv
realtim
pcr
biosewoom
seoul
korea
seeplex
rv
detect
kit
seegen
seoul
korea
result
confirm
use
sequenc
refer
result
among
sampl
identif
includ
coinfect
identif
respiratori
virus
onestep
rv
assay
seeplex
rv
assay
sequenc
respect
concord
rate
onestep
rv
assay
sequenc
seeplex
rv
assay
sequenc
p
sensit
onestep
rv
seeplex
rv
assay
confidenti
interv
ci
ci
respect
p
specif
onestep
rv
seeplex
rv
assay
ci
ci
respect
conclus
although
perform
onestep
rv
seeplex
rv
assay
overal
compar
onestep
rv
assay
show
better
sensit
concord
sequenc
onestep
rv
assay
use
option
respiratori
viru
test
clinic
laboratori
pleas
cite
paper
kim
h
hur
moon
hw
yun
ym
cho
hc
comparison
two
multiplex
pcr
assay
detect
respiratori
viral
infect
clin
respir
j
respiratori
viral
infect
major
caus
upper
lower
respiratori
tract
diseas
associ
signific
morbid
mortal
infant
children
elderli
immunocompromis
patient
diseas
sever
vari
accord
host
viral
predispos
factor
affect
age
immun
statu
patient
combin
infect
infect
mechan
viral
pathogen
respiratori
infect
caus
viru
bacteria
often
indistinguish
rapid
accur
detect
crucial
appropri
patient
treatment
prevent
endem
spread
therefor
select
appropri
diagnost
test
indispens
common
respiratori
virus
caus
respiratori
infect
includ
adenoviru
adv
coronavirus
cov
human
metapneumoviru
hmpv
influenza
viru
type
b
parainfluenza
viru
type
piv
piv
piv
respiratori
syncyti
viru
type
rsv
rsv
b
rhinovirus
enterovirus
bocavirus
although
convent
techniqu
includ
viral
isol
cell
cultur
serolog
use
diagnos
respiratori
viru
infect
clinic
valu
limit
weak
sensit
slow
turnaround
time
recent
rapid
antigen
test
use
wide
clinic
laboratori
known
less
sensit
less
specif
detect
respiratori
virus
molecular
assay
especi
polymeras
chain
reaction
pcr
increasingli
use
diagnosi
viral
infect
pcr
sensit
rapid
larg
autom
detect
quantifi
virus
amen
routin
cultur
moreov
simultan
detect
sever
virus
use
multiplex
pcr
assay
advantag
differenti
diagnosi
viral
respiratori
infect
one
assay
facilit
costeffect
clinic
field
studi
compar
two
commerci
avail
multiplex
pcr
assay
onestep
rv
realtim
pcr
biosewoom
inc
seoul
korea
seeplex
rv
detect
kit
seegen
inc
seoul
korea
seeplex
rv
assay
one
repres
multiplex
pcr
platform
perform
evalu
previou
studi
want
evalu
diagnost
perform
novel
multiplex
pcr
assay
onestep
rv
assay
comparison
seeplex
rv
assay
assay
compar
detect
follow
pathogen
respiratori
virus
adv
cov
hmpv
human
flu
human
flu
influenza
viru
type
b
piv
piv
piv
rhinoviru
rsv
rsv
b
specimen
posit
respiratori
virus
two
multiplex
pcr
assay
sequenc
confirm
pathogen
studi
approv
institut
review
board
konkuk
univers
medic
center
tertiari
referr
hospit
bed
juli
septemb
total
specimen
sputum
sampl
bronchoalveolar
lavag
sampl
nasal
swab
throat
swab
unknown
consecut
collect
patient
male
femal
respiratori
symptom
regardless
hospit
patient
consist
adult
children
median
age
year
year
respect
rang
year
bacteriolog
investig
smear
cultur
reveal
absenc
bacteri
coinfect
total
ml
specimen
ad
viral
transport
medium
minim
essenti
medium
fetal
bovin
serum
penicillin
uml
amphotericin
b
ugml
neomycin
ugml
nahco
buffer
aliquot
mixtur
sampl
store
analysi
viral
nucleic
acid
extract
use
qiaamp
minelut
viru
spin
kit
qiagen
valencia
ca
usa
accord
manufactur
instruct
brief
ul
proteas
ad
ul
specimen
buffer
al
solut
ad
specimen
proteas
mixtur
mixtur
incub
min
ul
ethanol
ad
entir
volum
sampl
transfer
qiaamp
minelut
column
centrifug
min
g
seri
wash
perform
extract
nucleic
acid
amplifi
onestep
rv
assay
seeplex
rv
assay
accord
manufactur
instruct
onestep
rv
realtim
pcr
conduct
final
reaction
volum
ul
contain
ul
sampl
rna
ul
posit
control
ul
neg
control
ul
rv
probeprim
mixtur
ul
master
mixtur
pcr
thermal
cycl
condit
optim
follow
protocol
min
min
cycl
follow
pcr
perform
use
biorad
realtim
detect
pcr
system
biorad
hercul
ca
usa
seeplex
rv
assay
endpoint
revers
transcriptas
pcr
use
dual
specif
oligonucleotid
technolog
cdna
synthesi
use
cdna
synthesi
kit
seegen
inc
pcr
conduct
final
reaction
volum
ul
contain
ul
cdna
ul
rv
primer
ul
master
mix
pcr
thermal
cycl
condit
optim
follow
protocol
min
revers
transcript
cycl
follow
min
min
final
extens
min
pcr
perform
use
geneamp
pcr
system
appli
biosystem
foster
citi
ca
usa
amplifi
pcr
product
separ
agaros
gel
seeplex
rv
assay
includ
size
marker
length
amplicon
intern
control
virus
specimen
show
amplicon
size
one
marker
band
indic
posit
limit
detect
target
virus
copiesul
onestep
rv
assay
copiesul
seeplex
rv
assay
assay
includ
intern
control
rule
pcr
inhibit
posit
result
multiplex
pcr
assay
confirm
use
sequenc
end
pcr
reaction
ul
enzymat
purif
mixtur
cocktail
contain
escherichia
coli
exonucleas
shrimp
alkalin
phosphatas
ad
pcr
product
mixtur
incub
min
follow
min
mixtur
kept
kept
mixtur
directli
sequenc
use
bigdy
termin
cycl
sequenc
kit
appli
biosystem
abi
prism
autosequenc
appli
biosystem
sequenc
analyz
use
basic
local
align
search
tool
blast
provid
nation
center
biotechnolog
inform
http
wwwncbinlmnih
govblast
concord
rate
multiplex
pcr
assay
sequenc
obtain
assay
sensit
specif
calcul
confid
interv
ci
proport
two
multiplex
assay
compar
use
chisquar
test
statist
analysi
perform
use
analyseit
softwar
analyseit
softwar
ltd
leed
uk
medcalc
softwar
version
medcalc
softwar
mariakerk
belgium
p
valu
equal
less
consid
statist
signific
total
result
obtain
specimen
result
result
posit
sequenc
onestep
rv
assay
seeplex
rv
assay
tabl
coronaviru
human
flu
human
flu
detect
specimen
among
type
virus
identifi
rhinoviru
hmpv
piv
frequent
detect
virus
overal
concord
rate
among
method
onestep
rv
seeplex
rv
assay
onestep
rv
assay
sequenc
seeplex
rv
assay
sequenc
concord
rate
multiplex
assay
sequenc
show
signific
differ
ci
p
coinfect
detect
specimen
tabl
two
multiplex
assay
show
discrep
result
coinfect
specimen
compar
discrep
result
total
specimen
proport
discrep
significantli
higher
coinfect
specimen
total
specimen
differ
ci
p
diagnost
perform
multiplex
assay
compar
sequenc
tabl
sensit
specif
onestep
rv
assay
ci
ci
respect
seeplex
rv
assay
sensit
specif
ci
ci
respect
sensit
onestep
rv
assay
significantli
higher
seeplex
rv
assay
vs
p
although
specif
compar
assay
onestep
rv
assay
show
excel
sensit
virus
sensit
lower
detect
rhinoviru
piv
piv
seeplex
rv
assay
excel
sensit
observ
influenza
viru
type
b
rsv
virus
sensit
vari
wide
rang
studi
show
diagnost
perform
two
multiplex
pcr
assay
detect
respiratori
virus
onestep
rv
seeplex
rv
assay
compar
sequenc
overal
concord
rate
onestep
rv
assay
significantli
better
seeplex
rv
assay
vs
p
tabl
influenza
viru
type
b
rsv
assay
show
concord
sequenc
virus
except
two
virus
concord
rate
onestep
rv
assay
superior
seeplex
rv
assay
specif
assay
compar
satisfactori
show
onestep
rv
assay
seeplex
rv
assay
tabl
high
perform
observ
constantli
viru
show
lowest
valu
piv
seeplex
rv
assay
howev
sensit
onestep
rv
assay
significantli
better
seeplex
rv
assay
vs
p
moreov
sensit
viru
variabl
seeplex
rv
assay
onestep
rv
assay
accur
rapid
diagnosi
respiratori
viru
infect
essenti
initi
earli
treatment
prevent
viral
spread
earli
start
proper
antivir
manag
avoid
unnecessari
exposur
antibacteri
agent
respiratori
viral
infect
caus
influenza
viru
adv
may
benefit
specif
antivir
treatment
know
subtyp
influenza
viru
may
import
predict
efficaci
adamantan
neuraminidas
inhibitor
antivir
agent
viral
cultur
technic
demand
easili
affect
specimen
qualiti
viru
type
although
shell
vial
cultur
subsequ
immunostain
wide
use
easi
routin
test
clinic
laboratori
nucleic
acid
amplif
test
includ
pcr
power
altern
respiratori
viru
detect
faster
sensit
viru
cultur
virus
grow
poorli
cell
cultur
also
detect
multiplex
pcr
assay
advantag
detect
common
respiratori
virus
simultan
wide
use
clinic
laboratori
accord
data
overal
perform
onestep
rv
assay
superior
seeplex
rv
assay
two
assay
show
signific
differ
term
sensit
concord
rate
sequenc
among
respiratori
viru
target
six
virus
show
sensit
onestep
rv
assay
compar
variabl
perform
seeplex
rv
assay
note
proport
discrep
two
multiplex
assay
significantli
higher
coinfect
specimen
total
specimen
vs
differ
ci
p
tabl
present
studi
proport
coinfect
rel
low
compar
previou
data
assum
overal
perform
concord
two
assay
would
shown
bigger
differ
could
enrol
coinfect
specimen
studi
studi
await
clarifi
assumpt
handson
time
seeplex
rv
assay
least
h
h
rna
extract
cdna
synthesi
addit
h
multiplex
pcr
visual
gel
electrophoresi
contrari
handson
time
onestep
realtim
rv
assay
reduc
approxim
h
without
step
cdna
synthesi
gel
electrophoresi
although
cost
per
case
may
similar
assay
improv
turnaround
time
onestep
rv
assay
would
benefici
save
overal
hospit
cost
time
report
studi
limit
enrol
sampl
size
small
analyz
result
clinic
specimen
two
assay
commerci
avail
compar
clinic
sampl
without
test
known
posit
control
target
virus
although
virus
identifi
use
onestep
rv
assay
analys
confin
virus
could
enrol
clinic
specimen
coronaviru
human
flu
human
flu
moreov
panel
assay
includ
common
respiratori
virus
enterovirus
bocavirus
absenc
virus
might
explain
rel
low
number
posit
sampl
set
clinic
specimen
anoth
studi
would
need
fulli
evalu
diagnost
perform
onestep
rv
assay
virus
anoth
limit
result
multiplex
pcr
assay
confirm
sequenc
without
viru
cultur
perform
howev
sequenc
gener
use
confirm
cultur
neg
pcr
posit
result
detect
poorli
grow
virus
cultur
conclus
novel
realtim
multiplex
pcr
platform
onestep
rv
assay
show
satisfactori
diagnost
perform
comparison
seeplex
rv
assay
excel
specif
sensit
onestep
rv
assay
one
use
option
respiratori
viru
test
clinic
viral
laboratori
